Revenue
2012
2013
2014
2015
2016
2021
2022
Processa Pharmaceuticals, Inc. (PCSA)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2012
2013
2014
2015
2016
2017
2023
2024
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $0 | — | — | — | — | $5,000 | $113,425 | $107,239 | $312,480 | $192,145 |
| Gross profit | — | — | — | — | — | — | — | — | — | $5,000 | −$12,451 | $40,406 | $124,478 | $58,890 |
| Research & development | $7.8M | $7.3M | $5.8M | $11.5M | $6.9M | $3.2M | $2.3M | $3.1M | $964,164 | $1.5M | $29,246 | $178,085 | $267,062 | $448,028 |
| Operating expenses | — | — | — | — | — | — | — | — | $1.8M | $1.9M | $2.7M | $3.4M | $3.1M | $2.3M |
| Operating income | −$14.0M | −$12.1M | −$11.5M | −$27.5M | −$12.1M | −$15.1M | −$3.9M | −$4.5M | −$1.8M | −$1.9M | — | — | — | — |
| EBITDAderived | — | — | — | — | −$11.3M | −$14.3M | −$3.1M | −$3.9M | — | — | — | — | — | — |
| Net income | −$13.6M | −$11.9M | −$11.1M | −$27.4M | −$11.4M | −$14.4M | −$3.4M | −$3.8M | −$1.9M | −$1.9M | −$3.4M | −$4.5M | −$3.1M | −$2.4M |
| Basic EPSper diluted share | -$10.36 | -$96.78 | -$8.48 | -$34.05 | -$0.75 | -$2.54 | -$0.70 | -$0.71 | -$0.06 | -$0.07 | -$0.31 | -$0.68 | -$0.61 | -$1.50 |
| Diluted EPSper diluted share | -$10.36 | -$96.78 | -$8.48 | -$34.05 | -$0.75 | -$2.54 | -$0.70 | -$0.71 | -$0.06 | -$0.07 | -$0.31 | -$0.68 | -$0.61 | -$1.50 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 15, 2026Form 4 | Young DavidPres. Research & Development | BuyCommon Stock | 2.1K | $2.22 | $4.6K | 19.2K |
| Jun 15, 2026Form 4 | SKIBSTED RUSSELLChief Financial Officer | BuyCommon Stock | 2.7K | $2.22 | $5.9K | 13.4K |
| Jun 15, 2026Form 4 | Ng George KChief Executive Officer | BuyCommon Stock | 2.5K | $2.22 | $5.5K | 12.4K |
| Jun 15, 2026Form 4 | Lin PatrickChief Business - Strategy Off | BuyCommon Stock | 1.8K | $2.22 | $4.1K | 11.0K |
| Jun 15, 2026Form 4 | Guy WendyChief Administrative Officer | BuyCommon Stock | 2.1K | $2.22 | $4.7K | 12.0K |